Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-06-02
1982-03-09
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112R, 260112B, 424 12, 546234, G01N 3356, G01N 3358, C07G 700, C07D21132
Patent
active
043188990
ABSTRACT:
A reliable and sensitive immunoassay for encainide in biological fluids including a novel hapten required for antigen synthesis and an immunologically homologous labeled tracer is provided.
REFERENCES:
patent: 3931195 (1976-01-01), Dykstra et al.
patent: 4070492 (1978-01-01), Spector
Mayol et al., Therapeutic Drug Monitoring, 1:507-524 (1979).
Byrne, et al., J. Pharmacol. Exp. Thera., 200:147-154 (1977).
Carnahan Robert E.
Mead Johnson & Company
Nucker Christine M.
Uloth Robert H.
LandOfFree
Encainide assay method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Encainide assay method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Encainide assay method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1840423